Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands

Nav

General Info

Geography

Netherlands (NLD)

Time period covered

01/2007 - 12/2012

Data type

Scientific literature

Keywords

HPV vaccines, Preventive interventions

Citation

Authors

Westra TA, Stirbu-Wagner I, Dorsman S, Tutuhatunewa ED, de Vrij EL, Nijman HW, Daemen T, Wilschut JC, Postma MJ

Journal

BMC Infect Dis

Volume

Pages

Publication year

2013

Suggested citation

Westra TA, Stirbu-Wagner I, Dorsman S, Tutuhatunewa ED, de Vrij EL, Nijman HW, Daemen T, Wilschut JC, Postma MJ. Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands. BMC Infect Dis. 2013; 13: 75.

DOI

10.1186/1471-2334-13-75

PMID

23390964

GHDx Entry last modified on: Jan 31, 2023

Header sites

Search form

Main menu

Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands

Nav